rs10049390
|
|
Colorectal Neoplasms
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1011970
|
|
Colorectal Neoplasms
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
|
27197191 |
2016 |
rs10152518
|
|
Colorectal Neoplasms
|
G |
0.700 |
GeneticVariation
|
GWASCAT |
Association analyses identify 31 new risk loci for colorectal cancer susceptibility.
|
31089142 |
2019 |
rs1023835002
|
|
Colorectal Neoplasms
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1023835002
|
|
Colorectal Neoplasms
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs1028166
|
|
Colorectal Neoplasms
|
G |
0.700 |
GeneticVariation
|
GWASCAT |
No evidence of gene-calcium interactions from genome-wide analysis of colorectal cancer risk.
|
25192705 |
2014 |
rs1035209
|
|
Colorectal Neoplasms
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
|
29917119 |
2019 |
rs1035209
|
|
Colorectal Neoplasms
|
T |
0.700 |
GeneticVariation
|
GWASCAT |
Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis.
|
24737748 |
2014 |
rs10411210
|
|
Colorectal Neoplasms
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
|
29917119 |
2019 |
rs10411210
|
|
Colorectal Neoplasms
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.
|
30529582 |
2019 |
rs10411210
|
|
Colorectal Neoplasms
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.
|
19011631 |
2008 |
rs10457678
|
|
Colorectal Neoplasms
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
|
26621817 |
2015 |
rs104886003
|
|
Colorectal Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs104886003
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs104886003
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials.
|
22162582 |
2012 |
rs104886003
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs104886003
|
|
Colorectal Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs104886003
|
|
Colorectal Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials.
|
22162582 |
2012 |
rs104886003
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs104886003
|
|
Colorectal Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs104886003
|
|
Colorectal Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs104886003
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs104886003
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.
|
19223544 |
2009 |
rs104886003
|
|
Colorectal Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations predict local recurrences in rectal cancer patients.
|
19903786 |
2009 |
rs104886003
|
|
Colorectal Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer.
|
19366826 |
2009 |